Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Jose R. Conejo-Garcia"'
Autor:
Jose R. Conejo-Garcia, Ozlen Saglam
Publikováno v:
Integrative Cancer Science and Therapeutics. 5
Programmed cell death-1 and programmed cell death ligand-1 (PD-1/PD-L1) blockage has become an important treatment modality after approval of pembrolizumab and nivolumab by Food and Drug Administration in advanced cancers. Patients with metastatic an